GILEAD SCIENCES, INC. bought RCUS

February 18, 2025 · Form 4 insider transaction

GILEAD SCIENCES, INC. bought 1,363,636 shares of Arcus Biosciences, Inc. at $11.00 per share, a transaction worth $15.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.